Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
HOUSTON, TX--(Marketwired - March 27, 2018) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based …